Centene Corp

Centene Corp

Health CareHealth Care Equipment & Services
  • Price (USD)46.72
  • Today's Change1.18 / 2.59%
  • Shares traded2.05m
  • 1 Year change-35.72%
  • Beta0.8304
Data delayed at least 15 minutes, as of Oct 17 2019 18:25 BST.
More ▼

Profile data is unavailable for this security.

About the company

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company's Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.

  • Revenue in USD (TTM)69.54bn
  • Net income in USD1.28bn
  • Incorporated2001
  • Employees47.30k
  • Location
    Centene Corp7700 Forsyth BlvdST. LOUIS 63105-1807United StatesUSA
  • Phone+1 (314) 725-4477
  • Fax+1 (302) 655-5049
  • Websitehttps://www.centene.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CNC:NYQ since
HealthSmart Holdings IncDeal completed01 May 201901 May 2019Deal completed-9.39%--
WellCare Health Plans IncAnnounced27 Mar 201927 Mar 2019Announced-14.82%15.57bn
Torrejon Salud SADeal completed08 Nov 201808 Nov 2018Deal completed-34.64%--
Data delayed at least 15 minutes, as of Oct 17 2019 18:25 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Amedisys Inc1.81bn123.88m4.26bn21.00k35.097.5730.522.353.773.7755.1617.481.85--8.2986,287.4812.756.1017.478.4440.5141.406.893.12--52.800.32750.0010.015.88130.84---30.94--
Encompass Health Corp4.42bn309.30m6.41bn30.06k20.865.0310.651.453.123.1344.3312.930.8114--9.29147,125.807.217.369.319.0196.3596.038.899.08--5.020.587534.859.2813.747.614.954.5523.64
Chemed Corporation1.84bn200.97m6.62bn15.71k34.3910.6527.433.6012.0912.09110.5739.051.82210.1014.39116,971.9019.8813.8024.6317.7531.2030.0210.947.650.777245.340.139813.416.964.75128.7121.6312.518.83
Molina Healthcare, Inc.17.67bn792.00m7.40bn11.00k9.914.288.290.418711.9011.90265.4627.562.29--14.811,606,636.0010.251.5825.363.8617.8014.744.480.6301--10.500.47090.00-4.9923.45254.3773.61-21.09--
Davita Inc11.25bn547.52m9.14bn77.70k17.342.326.860.8123.290.812367.5624.620.571876.485.84144,842.603.714.455.565.6528.8029.146.486.881.102.870.6230.004.86-0.6183-6.17-0.12179.83--
Universal Health Services, Inc.11.06bn794.54m12.80bn78.70k16.622.379.981.168.718.77120.8360.950.9695--7.00140,571.407.117.358.258.69----7.337.541.177.010.43145.373.487.897.028.6411.4214.87
WellCare Health Plans, Inc.24.90bn523.80m13.51bn12.00k25.722.9417.540.542610.4410.38496.5591.502.13--25.072,075,100.004.493.738.916.9098.46--2.101.51--8.050.3110.0020.0316.4639.4520.3719.88--
Quest Diagnostics Inc7.57bn708.00m14.25bn46.00k20.542.6213.731.885.155.2955.0740.440.672950.147.07164,608.706.326.777.457.8035.1036.999.399.200.76736.870.415934.131.741.068.45-2.3810.6410.20
Laboratory Corp. of America Holdings11.29bn882.70m16.61bn61.00k19.412.3311.601.478.768.46112.3373.050.659436.035.74185,109.805.165.175.975.9228.1331.017.837.211.056.850.48290.009.9514.3031.1410.1113.44--
Centene Corp69.54bn1.28bn18.84bn47.30k14.971.5510.120.27093.043.04165.7029.392.20--15.021,470,
Humana Inc60.73bn2.53bn37.20bn41.60k14.883.1312.210.612618.5118.32443.4687.881.92----1,459,760.007.935.92--------4.132.74--14.700.333114.095.856.62-33.286.946.7712.38
HCA Healthcare Inc48.84bn3.34bn41.41bn262.00k12.77--6.510.84779.5110.38139.04-11.431.174.657.07186,427.509.489.1512.6011.8083.5283.268.077.381.233.901.053.927.026.4328.5715.7712.96--
CVS Health Corp227.26bn4.22bn85.07bn295.00k18.851.3910.860.37433.473.56191.4547.181.2910.1414.39770,355.902.404.003.125.4332.0917.941.862.310.63573.750.536444.935.308.95-113.63--0.528717.32
Data as of Oct 17 2019. Currency figures normalised to Centene Corp's reporting currency: US Dollar USD

Institutional shareholders

44.76%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 201942.21m10.21%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 201932.06m7.75%
Capital Research & Management Co. (World Investors)as of 30 Jun 201930.51m7.38%
BlackRock Fund Advisorsas of 30 Jun 201920.81m5.03%
SSgA Funds Management, Inc.as of 30 Jun 201916.63m4.02%
Viking Global Investors LPas of 30 Jun 201913.99m3.38%
Fidelity Management & Research Co.as of 30 Jun 20199.99m2.42%
Capital Research & Management Co. (International Investors)as of 30 Jun 20196.88m1.66%
Maverick Capital Ltd.as of 30 Jun 20196.12m1.48%
Geode Capital Management LLCas of 30 Jun 20195.91m1.43%
More ▼
Data from 30 Jun 2019 - 30 Jun 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.